Adma Biologics (ADMA) Income from Continuing Operations (2011 - 2026)
Adma Biologics (ADMA) reported Income from Continuing Operations of $37.82 million for Q2 2026, up 10.5% from $34.22 million a year earlier but down 16.6% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Adma Biologics' Income from Continuing Operations came in at $168.96 million, down 19.1% year-over-year; for FY2025, it came in at $146.93 million, down 25.7% from FY2024.
- By year, Income from Continuing Operations came in at $197.67 million in FY2024, -$28.24 million in FY2023, -$65.9 million in FY2022 and -$71.4 million in FY2021.
- Five-year quarterly Income from Continuing Operations spans a low of -$18.17 million in Q1 2022 and a high of $111.9 million in Q4 2024.
- Year over year, Income from Continuing Operations gained in five of the last six quarters, with growth averaging 13.7%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $45.33 million (Q1 2026), $49.38 million (Q4 2025) and $36.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Adma Biologics | 2.26 Bn | 1.84 Bn | 86.28 Mn | 37.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.82 Mn |
| Mar 31, 2026 | 45.33 Mn |
| Dec 31, 2025 | 49.38 Mn |
| Sep 30, 2025 | 36.43 Mn |
| Jun 30, 2025 | 34.22 Mn |
| Mar 31, 2025 | 26.90 Mn |
| Dec 31, 2024 | 111.90 Mn |
| Sep 30, 2024 | 35.91 Mn |
| Jun 30, 2024 | 32.06 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | -17.65 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | -6.37 Mn |
| Mar 31, 2023 | -6.79 Mn |
| Dec 31, 2022 | -11.79 Mn |
| Sep 30, 2022 | -14.89 Mn |
| Jun 30, 2022 | -13.75 Mn |
| Mar 31, 2022 | -18.17 Mn |
| Dec 31, 2021 | -16.50 Mn |
| Sep 30, 2021 | -17.73 Mn |
API Access
Adma Biologics Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();